Clinical trial
A Double-Blind, Placebo-Controlled Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain
NCT00363376 is registered in ClinicalTrials.gov with Lindner Center of HOPE as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain
- Lead sponsor
- Lindner Center of HOPE
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- February 28, 2011
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.